TerminatedNCT03638466
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD
Medication studyAges 8–12United States
Understand this study
Who could participate?
This study is for people with ADHD. Listed age limits: 8 years to 12 years. Other eligibility criteria apply.
- Listed locations
- Lakeland and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 30, 2019
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 7
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, DIAGNOSTIC_TEST, Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 8 Years to 12 Years
- Official registry ID
- NCT03638466
- Official title
Show the full official title
Exploratory Neuroimaging Study to Evaluate the Effect on Brain Activity of SPN-810 for Impulsive Aggression (IA) in Patients With Attention-Deficit/Hyperactivity Disorder (ADHD) in Conjunction With Standard ADHD Treatment
Recruitment & locations
TerminatedLakeland · Maitland · Tampa
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Supernus Pharmaceuticals, Inc., a pharmaceutical company.
Does this study involve medication?
Yes. The study involves medication, including SPN-810 and Placebo.
Who can participate?
This study is for people with ADHD. Listed age limits: 8 years to 12 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
